These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 34529738)
1. The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway. Furuyama W; Shifflett K; Feldmann H; Marzi A PLoS Pathog; 2021 Sep; 17(9):e1009937. PubMed ID: 34529738 [TBL] [Abstract][Full Text] [Related]
2. The Roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Countermeasure Development. Zhu W; Banadyga L; Emeterio K; Wong G; Qiu X Viruses; 2019 Oct; 11(11):. PubMed ID: 31683550 [TBL] [Abstract][Full Text] [Related]
3. Soluble Glycoprotein Is Not Required for Ebola Virus Virulence in Guinea Pigs. Hoenen T; Marzi A; Scott DP; Feldmann F; Callison J; Safronetz D; Ebihara H; Feldmann H J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S242-6. PubMed ID: 25957965 [TBL] [Abstract][Full Text] [Related]
4. RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor. Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE J Infect Dis; 2015 Oct; 212 Suppl 2():S226-33. PubMed ID: 26138826 [TBL] [Abstract][Full Text] [Related]
5. The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. Groseth A; Marzi A; Hoenen T; Herwig A; Gardner D; Becker S; Ebihara H; Feldmann H PLoS Pathog; 2012; 8(8):e1002847. PubMed ID: 22876185 [TBL] [Abstract][Full Text] [Related]
6. Ebola virus secreted glycoprotein decreases the anti-viral immunity of macrophages in early inflammatory responses. Bradley JH; Harrison A; Corey A; Gentry N; Gregg RK Cell Immunol; 2018 Feb; 324():24-32. PubMed ID: 29195741 [TBL] [Abstract][Full Text] [Related]
7. Structures of Ebola virus GP and sGP in complex with therapeutic antibodies. Pallesen J; Murin CD; de Val N; Cottrell CA; Hastie KM; Turner HL; Fusco ML; Flyak AI; Zeitlin L; Crowe JE; Andersen KG; Saphire EO; Ward AB Nat Microbiol; 2016 Aug; 1(9):16128. PubMed ID: 27562261 [TBL] [Abstract][Full Text] [Related]
8. NK Cells Accumulate in Infected Tissues and Contribute to Pathogenicity of Ebola Virus in Mice. Fausther-Bovendo H; Qiu X; He S; Bello A; Audet J; Ippolito G; Wong G; Kobinger G J Virol; 2019 May; 93(10):. PubMed ID: 30814283 [TBL] [Abstract][Full Text] [Related]
9. Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity. Dolnik O; Volchkova VA; Escudero-Perez B; Lawrence P; Klenk HD; Volchkov VE J Infect Dis; 2015 Oct; 212 Suppl 2():S322-8. PubMed ID: 26092855 [TBL] [Abstract][Full Text] [Related]
10. Importin-α7 Is Involved in the Formation of Ebola Virus Inclusion Bodies but Is Not Essential for Pathogenicity in Mice. Gabriel G; Feldmann F; Reimer R; Thiele S; Fischer M; Hartmann E; Bader M; Ebihara H; Hoenen T; Feldmann H J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S316-21. PubMed ID: 26185094 [TBL] [Abstract][Full Text] [Related]
11. A new Ebola virus nonstructural glycoprotein expressed through RNA editing. Mehedi M; Falzarano D; Seebach J; Hu X; Carpenter MS; Schnittler HJ; Feldmann H J Virol; 2011 Jun; 85(11):5406-14. PubMed ID: 21411529 [TBL] [Abstract][Full Text] [Related]
12. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism. González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839 [TBL] [Abstract][Full Text] [Related]
13. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein. Bagdonaite I; Abdurahman S; Mirandola M; Pasqual D; Frank M; Narimatsu Y; Joshi HJ; Vakhrushev SY; Salata C; Mirazimi A; Wandall HH J Virol; 2024 Jun; 98(6):e0052424. PubMed ID: 38757972 [TBL] [Abstract][Full Text] [Related]
14. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs. Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737 [TBL] [Abstract][Full Text] [Related]
15. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE J Infect Dis; 2011 Nov; 204 Suppl 3():S941-6. PubMed ID: 21987773 [TBL] [Abstract][Full Text] [Related]